Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

We recently published 10 Big Names With Explosive Growth. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals jumped by 16.44 percent on ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Amilcar has 10 years of FinTech, blockchain, ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Gearbox has big plans for Borderlands 4’s next big patch. Gearbox associate creative director Grant Kao made this announcement on Twitter: @ProdigyXL (AKA creative director Graeme Timmins) and I have ...

Attorney General Pamela Bondi on Monday defended a controversial Trump administration proposal to eliminate the ATF and merge its functions into the Drug Enforcement Administration. The plan, outlined ...

Albom's new novel, Twice, asks a question most of us have daydreamed about: what if you could go back and relive any moment of your life? In the book, a man is born with that exact power, but every ...